“Harmful Algae: Natural Products Research and Medical Application Exploration”―Selected Papers from the 18th International Conference on Harmful Algae (ICHA 2018)
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 November 2018) | Viewed by 5144
Special Issue Editors
Interests: marine algal; bacterial and cyanobacterial toxins; mass spectrometric analysis of and biological assays for toxins and related metabolites; ecophysiology of toxin production and biosynthesis; HABs and climate change; reference materials; monitoring and risk evaluation
Special Issues, Collections and Topics in MDPI journals
Interests: marine natural products
Special Issue Information
Dear Colleagues,
Aquatic phytoplankton (dinoflagellates, cyanobacteria, and diatoms) accounts for ~50% of oxygen and biomass production on Earth, therefore playing a principal role as a carbon dioxide sink. Phytoplankton lifestyle is characterized by massive proliferation (~100,000–1,000,000 cells L-1) covering large aquatic surface areas. Harmful algal blooms (HABs) are detrimental for aquatic ecosystems and when dominated by toxic species, they seriously affect economic activities (fishing, aquaculture, tourism) and public health. It is estimated however that only ~2% of phytoplankton species are able to produce toxins. Worldwide development of marine and freshwater HABs has significantly increased in the last century due to anthropogenic impacts and global climate change affecting the geographical distribution of toxic species and toxin emergence. The International Conference on Harmful Algae ICHA 2018 will take place in Nantes (France) from 21st to 26th October 2018. According to the motto “From ecosystems to socio-ecosystems” and with 21 themes covering all research areas on HABs, from molecular over cellular and organismal levels to eco-physiological and societal levels, ICHA 2018 aims to contribute to the crosstalk between the international scientific community and political deciders on Global Change, HABs and societal challenges.
This Special Issue in Marine Drugs is suited to receive contributions from several of the topics outlined on the website of the 18th ICHA conference (https://www.icha2018.com/scientific-program/session-topics/35). In particular, all topics describing the analysis, biosynthesis and production of algal and cyanobacterial metabolites and their bio-activity, i.e.,
- Medical applications of algae, cyanobacteria and their toxins
- Biotechnology or adding value to toxic and harmful algae
- Novel detection methods "Omic" technologies: Genomics, transcriptomics, proteomics and metabolomics of HABs
- Human Toxicology
- Ciguatera and related benthic HAB organisms and toxins
Dr. Philipp Hess
Dr. Romulo Araoz
Dr. Benjamin Marie
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
